Management of Pleural Effusion Secondary to Malignant Mesothelioma

被引：1

作者：

Musso, Valeria ^{[1
,2
]}

Diotti, Cristina ^{[1
,2
]}

Palleschi, Alessandro ^{[1
,2
]}

Tosi, Davide ^{[1
]}

Aiolfi, Alberto ^{[3
,4
]}

Mendogni, Paolo ^{[1
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Thorac Surg & Lung Transplantat Unit, I-20122 Milan, Italy

[2] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy

[3] Univ Milan, Dept Biomed Sci Hlth, I-20133 Milan, Italy

[4] Ist Clin St Ambrogio, Div Gen Surg, I-20149 Milan, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 18期

关键词：

malignant pleural effusion; malignant pleural mesothelioma; mesothelioma; indwelling pleural catheter; talc poudrage; TALC PLEURODESIS; EFFICACY; DIAGNOSIS; CATHETER;

D O I：

10.3390/jcm10184247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Malignant pleural mesothelioma (MPM) is a highly aggressive pleural tumour which has been epidemiologically linked to occupational exposure to asbestos. MPM is often associated with pleural effusion, which is a common cause of morbidity and whose management remains a clinical challenge. In this review, we analysed the literature regarding the diagnosis and therapeutic options of pleural effusion secondary to mesothelioma. Our aim was to provide a comprehensive view on this subject, and a new algorithm was proposed as a practical aid to clinicians dealing with patients suffering from pleural effusion.

引用

页数：9

共 50 条

[41] Biology and management of malignant pleural mesothelioma
Zucali, Paolo A.
Giaccone, Giuseppe
EUROPEAN JOURNAL OF CANCER, 2006, 42 (16) : 2706 - 2714
[42] Multimodality Management of Malignant Pleural Mesothelioma
Cengel, K. A.
Fernandes, A.
Mick, R.
Culligan, M.
Smith, D.
Stevenson, I.
Sterman, D.
Glatstein, E.
Hahn, S.
Friedberg, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S503 - S504
[43] Trimodality management of malignant pleural mesothelioma
Maggi, G
Casadio, C
Cianci, R
Rena, O
Ruffini, E
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 19 (03) : 346 - 350
[44] Modern management of malignant pleural mesothelioma
Patel, Shivani C.
Dowell, Jonathan E.
LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 63 - 72
[45] Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
Tsuji, S.
Tsuura, Y.
Morohoshi, T.
Shinohara, T.
Oshita, F.
Yamada, K.
Kameda, Y.
Ohtsu, T.
Nakamura, Y.
Miyagi, Y.
BRITISH JOURNAL OF CANCER, 2010, 103 (04) : 517 - 523
[46] Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion
Yamazoe, Masatoshi
Ozasa, Hiroaki
Hak, Young
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : E251 - E253
[47] Management of the Patient with a Malignant Pleural Effusion
Heffner, John E.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 31 (06) : 723 - 733
[48] Advances in the management of malignant pleural effusion
Debiane, Labib G.
Ost, David E.
CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (04) : 317 - 322
[49] Management of malignant pleural effusion Reply
Davies, Helen E.
Thomas, Rajesh
Francis, Roslyn
Lee, Y. C. Gary
RESPIROLOGY, 2015, 20 (01) : 170 - 171
[50] Malignant pleural effusion and algorithm management
Zarogoulidis, Konstantinos
Zarogoulidis, Paul
Darwiche, Kaid
Tsakiridis, Kosmas
Machairiotis, Nikolaos
Kougioumtzi, Ioanna
Courcoutsakis, Nikolaos
Terzi, Eirini
Zaric, Bojan
Huang, Haidong
Freitag, Lutz
Spyratos, Dionysios
JOURNAL OF THORACIC DISEASE, 2013, 5 : S413 - S419

← 1 2 3 4 5 →